Linnea
Linnea
Assuring Excellence

Linnea’s Butylscopolamine

A peripherally-acting antimuscarinic and anticholinergic agent, Linnea has produced butylscopolamine in its manufacturing facilities since 1985, obtaining this semi-synthetic derivative from the leaves of the Duboisia plant.

Origins

Plant
Duboisia

Part of the plant used
Leaves

appearance
White or almost white Crystalline powder

cas number
149-64-4

 

USES / Pharmaceutical

Abdominal spasm

Renal colic pain

Smooth-muscle relaxation

Dysmenorrhea

PRODUCTS

BUTYLSCOPOLAMINE
ORAL GRADE
Semi-synthetic derivative
Suitable for oral pharmaceutical forms

HYJECT™ (suitable for injectable)
Semi-synthetic derivative
Non-sterile suitable for injectable
pharmaceutical forms

COMPLIES WITH PH. EUR. “HYOSCINE BUTYLBROMIDE” MONOGRAPH CURRENT EDITION
Certifications

All information is subject to updates. Please get in touch with our team to get updates.

BUTYLSCOPOLAMINE

SEMI-SYNTHETIC DERIVATIVE

More at linnea.ch

Contact Us

Don’t hesitate to contact us for more information about our processes and products